FI964509A0 - Modulators of TNF / NGF superfamily receptors and soluble oligomeric TNF / NGF superfamily receptors - Google Patents

Modulators of TNF / NGF superfamily receptors and soluble oligomeric TNF / NGF superfamily receptors

Info

Publication number
FI964509A0
FI964509A0 FI964509A FI964509A FI964509A0 FI 964509 A0 FI964509 A0 FI 964509A0 FI 964509 A FI964509 A FI 964509A FI 964509 A FI964509 A FI 964509A FI 964509 A0 FI964509 A0 FI 964509A0
Authority
FI
Finland
Prior art keywords
tnf
superfamily receptors
ngf superfamily
modulators
ngf
Prior art date
Application number
FI964509A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI964509A (en
Inventor
David Wallach
Mark Boldin
Igor Mett
Eugene Varfolomeev
Original Assignee
Yeda Res & Dev
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IL109632A external-priority patent/IL109632A/en
Application filed by Yeda Res & Dev filed Critical Yeda Res & Dev
Publication of FI964509A0 publication Critical patent/FI964509A0/en
Publication of FI964509A publication Critical patent/FI964509A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7151—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for tumor necrosis factor [TNF], for lymphotoxin [LT]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/67—General methods for enhancing the expression
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
FI964509A 1994-05-11 1996-11-08 TNF / NGF superfamily receptor transformers and soluble, oligomeric superfamily receptors FI964509A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IL109632A IL109632A (en) 1994-05-11 1994-05-11 Modulators of the function of tnf receptors
IL11112594A IL111125A0 (en) 1994-05-11 1994-10-02 Soluble oligomeric tnf/ngf super family ligand receptors and their use
PCT/US1995/005854 WO1995031544A1 (en) 1994-05-11 1995-05-11 Modulator of tnf/ngf superfamily receptors and soluble oligomeric tnf/ngf superfamily receptors

Publications (2)

Publication Number Publication Date
FI964509A0 true FI964509A0 (en) 1996-11-08
FI964509A FI964509A (en) 1997-01-09

Family

ID=26322830

Family Applications (1)

Application Number Title Priority Date Filing Date
FI964509A FI964509A (en) 1994-05-11 1996-11-08 TNF / NGF superfamily receptor transformers and soluble, oligomeric superfamily receptors

Country Status (10)

Country Link
EP (1) EP0759984A4 (en)
JP (1) JP3966387B2 (en)
KR (1) KR100404737B1 (en)
CN (2) CN1173033C (en)
AU (1) AU703919B2 (en)
CA (1) CA2189983A1 (en)
FI (1) FI964509A (en)
IL (1) IL111125A0 (en)
NO (1) NO321514B1 (en)
WO (1) WO1995031544A1 (en)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5663070A (en) * 1993-11-15 1997-09-02 Lxr Biotechnology Inc. Recombinant production of a soluble splice variant of the Fas (Apo-1) antigen, fas TM
US5849501A (en) * 1994-10-19 1998-12-15 Genetics Institute, Inc. TNF receptor death domain ligand proteins and method to identify inhibitors of ligand binding
US5712381A (en) 1994-10-19 1998-01-27 Genetics Institute, Inc. MADD, a TNF receptor death domain ligand protein
US5852173A (en) * 1994-10-19 1998-12-22 Genetics Institute, Inc. TNF receptor death ligand proteins and inhibitors of ligand binding
US5847099A (en) * 1994-10-19 1998-12-08 Genetics Institute, Inc. TNF receptor death domain ligand proteins
IL114615A0 (en) * 1995-07-16 1995-11-27 Yeda Res & Dev Modulators of the function of fas receptors and other proteins
US6060238A (en) * 1995-02-13 2000-05-09 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
US7097972B1 (en) 1995-02-13 2006-08-29 Regents Of The University Of Michigan Method and composition for regulating apoptosis
US6015665A (en) * 1995-02-13 2000-01-18 The Regents Of The University Of Michigan Method and composition for regulating apoptosis
PT813419E (en) * 1995-02-22 2005-09-30 Yeda Res & Dev REGULATORY PROTEIN MODULATORS
US6355780B1 (en) 1995-02-22 2002-03-12 Yeda Research And Development Co. Ltd. Antibodies to the death domain motifs of regulatory proteins
US6747138B1 (en) 1995-04-03 2004-06-08 Regents Of The University Of Michigan Methods and compositions for regulating Fas-associated apoptosis
US7807783B1 (en) 1995-04-03 2010-10-05 The Regents Of The University Of Michigan Methods and compositions for regulating FAS-associated apoptosis
US6399327B1 (en) 1995-07-16 2002-06-04 Yeda Research And Development Co. Ltd. Modulators of the function of FAS receptors and other proteins
US6998116B1 (en) 1996-01-09 2006-02-14 Genentech, Inc. Apo-2 ligand
US6030945A (en) * 1996-01-09 2000-02-29 Genentech, Inc. Apo-2 ligand
EP1557432B1 (en) 1996-02-20 2013-08-21 Merck Serono SA Hybrid proteins which form heterodimers
EA002474B1 (en) * 1996-02-20 2002-06-27 Апплайд Резеч Системз Арс Холдинг Н.В. Hybrid protein which form heterodimers, metod for producing the same and use
JP2000507829A (en) 1996-04-01 2000-06-27 ジェネンテック インコーポレーテッド APO-2LI and APO-3 apoptotic polypeptide
AU6721696A (en) * 1996-07-15 1998-03-06 Human Genome Sciences, Inc. Cd44-like protein
US6462176B1 (en) 1996-09-23 2002-10-08 Genentech, Inc. Apo-3 polypeptide
CA2273185A1 (en) 1996-11-05 1998-05-14 Board Of Regents, The University Of Texas System Compositions and uses for sentrin, a cell-death protecting protein
US6930084B1 (en) 1996-11-06 2005-08-16 The Regents Of The University Of California Treating arthritis with TNF receptor releasing enzyme
US6593456B1 (en) 1996-11-06 2003-07-15 The Regents Of The University Of California Tumor necrosis factor receptor releasing enzyme
ATE403714T1 (en) 1996-11-06 2008-08-15 Univ California TUMOR NECROSIS FACTOR RECEPTOR SEPARATING ENZYME, PREPARATIONS AND USES THEREOF
US5858990A (en) * 1997-03-04 1999-01-12 St. Elizabeth's Medical Center Fas ligand compositions for treatment of proliferative disorders
US6342369B1 (en) 1997-05-15 2002-01-29 Genentech, Inc. Apo-2-receptor
US7001992B2 (en) 1997-05-30 2006-02-21 Human Genome Sciences, Inc. Antibodies to secreted protein HEMCM42
DK1015477T3 (en) * 1997-05-30 2011-02-07 Human Genome Sciences Inc 32 human secreted proteins
IL121746A0 (en) * 1997-06-05 1998-02-22 Yeda Res & Dev Modulators of intracellular cell death and cell survival pathways
US6051385A (en) * 1997-10-22 2000-04-18 The Regents Of The University Of Michigan Compositions and methods for identifying and testing therapeutics against HSV infection
WO1999028465A2 (en) * 1997-11-28 1999-06-10 The Regents Of The University Of California Pias molecules that recognize and bind stat proteins and uses thereof
WO1999036535A1 (en) 1998-01-15 1999-07-22 Genentech, Inc. Apo-2 ligand
US6207422B1 (en) 1998-04-17 2001-03-27 The Metrohealth System Protein that enhances expression of potassium channels on cell surfaces and nucleic acids that encode the same
EP1022027A1 (en) * 1999-01-22 2000-07-26 Applied Research Systems ARS Holding N.V. Tumor necrosis factor antagonists and their use in endometriosis
JP2001078776A (en) 1999-09-14 2001-03-27 Inst Of Physical & Chemical Res Nade-binding protein
EP3474016A1 (en) 2008-12-10 2019-04-24 Joslin Diabetes Center, Inc. Methods of diagnosing and predicting renal disease
WO2014127835A1 (en) 2013-02-22 2014-08-28 Christian-Albrechts-Universität Zu Kiel Plant-derived resistance gene

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5395760A (en) * 1989-09-05 1995-03-07 Immunex Corporation DNA encoding tumor necrosis factor-α and -β receptors
DK0939121T4 (en) * 1989-09-12 2008-02-04 Ahp Mfg B V TNF-binding proteins
CA2067031C (en) * 1991-04-26 2003-02-18 Shigekazu Nagata Dna coding for human cell surface antigen

Also Published As

Publication number Publication date
NO964741D0 (en) 1996-11-08
KR100404737B1 (en) 2004-05-03
JP3966387B2 (en) 2007-08-29
WO1995031544A1 (en) 1995-11-23
FI964509A (en) 1997-01-09
CN1152937A (en) 1997-06-25
NO321514B1 (en) 2006-05-15
AU2546995A (en) 1995-12-05
AU703919B2 (en) 1999-04-01
NO964741L (en) 1997-01-09
CN1329512C (en) 2007-08-01
CN1616661A (en) 2005-05-18
EP0759984A4 (en) 2002-06-26
JPH10500568A (en) 1998-01-20
CA2189983A1 (en) 1995-11-23
EP0759984A1 (en) 1997-03-05
CN1173033C (en) 2004-10-27
IL111125A0 (en) 1994-12-29
KR970703419A (en) 1997-07-03

Similar Documents

Publication Publication Date Title
FI964509A0 (en) Modulators of TNF / NGF superfamily receptors and soluble oligomeric TNF / NGF superfamily receptors
FI955362A0 (en) Symmetry device and method of construction thereof
FI934361A (en) Foerfarande and anordning Foer evaluato av vaegningsparametrarna Foer en signal i en mottagare
FI954926A0 (en) New polysaccharides and their preparation
FI935154A (en) REFERRALS FOR THE ESTABLISHMENT OF SIGNAL REQUIREMENTS PARAMETERS AND ENTRY
FI923478A (en) FRAMEWORK FOR ORGANIZATION OF CHARACTERISTICS AND POLYMERS
DE69635343D1 (en) DETERMINATION OF PARTICLE SIZE DISTRIBUTION IN A LIQUID
DE69607487T2 (en) INCREASE IN RESOLUTION OF FIXED POINT DIGITAL FILTERS
NO973826D0 (en) New use of mother-of-pearl preparations
EE03499B1 (en) Apparatus and method of telecommunications
FI974486A0 (en) Optical weight is used and fares are used
FI97983B (en) Screening procedure and screening
FI953736A0 (en) I have been asked to provide and support measures
FI971085A (en) New PKA-binding proteins and their use
DE59601003D1 (en) DEVICE OF COMMUNICATION MEASUREMENT TECHNOLOGY
KR970008272U (en) Simultaneous sorting of sand and gravel
IL112692A0 (en) Modulators of tnf/ngf superfamily receptors, their preparation and use
FI974496A0 (en) Foer farande and anordning Foer modulating av en signal
KR970025006U (en) Filter set of viscometer
ID16681A (en) MAKING OF FORMSZAN COLORING FIXED MATERIALS
FI954954A0 (en) Foerfarande och anordning Foer balning av straoaktiga produkter
FI962568A0 (en) Use of a safety device and a safety deviceUse of a safety device and a safety device to improve public safety
FI954564A0 (en) Foerfarande och naet Foer granskning av vattenomraodes botten
FI951094A0 (en) Foerfarande and anordningar Foer utnyttjande av vaogenergi
FI953063A0 (en) Traod and foarfarande Foer framstaellning av traod

Legal Events

Date Code Title Description
FD Application lapsed